| Literature DB >> 24943829 |
Laura Elise Vogl, Nicola Clare Newton1, Katrina Elizabeth Champion, Maree Teesson.
Abstract
BACKGROUND: Psychostimulants and cannabis are two of the three most commonly used illicit drugs by young Australians. As such, it is important to deliver prevention for these substances to prevent their misuse and to reduce associated harms. The present study aims to evaluate the feasibility and effectiveness of the universal computer-based Climate Schools: Psychostimulant and Cannabis Module.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24943829 PMCID: PMC4074146 DOI: 10.1186/1747-597X-9-24
Source DB: PubMed Journal: Subst Abuse Treat Prev Policy ISSN: 1747-597X
Lesson content of the Climate Schools: Psychostimulant and Cannabis Module
| Cannabis: What is it? | |
| Short-term effects of cannabis | |
| Reasons people use cannabis | |
| Cannabis and the law | |
| Risk and protective factors for drug use | |
| Conservative norms: prevalence of cannabis use | |
| Mental health and cannabis | |
| Critical analysis of drug-related internet and media resources | |
| Classifying drugs: hallucinogens, stimulants and depressants | |
| Psychostimulants: What are they? | |
| Common names and properties of psychostimulant drugs | |
| Short-term effects of psychostimulants | |
| Conservative norms: Prevalence of psychostimulant use | |
| The multifaceted nature of the effects of drug use on people’s lives | |
| Definitions, examples and effects of poly-drug use | |
| Classifying drugs | |
| The indirect negative consequences of drug use | |
| Problem solving and decision making skills in relation to drugs | |
| Identifying drug related risk and minimising drug related harms | |
| Communication skills | |
| Avenues for seeking help and barriers to accessing services | |
| What to do in a drug related emergency | |
| Calling 000, the emergency number | |
| Identifying communication styles, including assertiveness | |
| Long-term effects of drugs | |
| Drug withdrawal | |
| Harm-minimisation strategies | |
| Learning about resilience | |
| Attitudes to drug use | |
| Prevalence of psychostimulants and cannabis use | |
| CPR and first aid | |
| Drugs and driving | |
| Drugs and the law | |
| Problem solving skills | |
| Legalisation, decriminalisation and criminalization of drugs – the debate | |
| The effects of drugs on life’s journey | |
| The effects of drugs on others |
Intervention and assessment times
| Term 2 | Term 2&3 | Term 2&3 | Term 4 | Term 2 | |
| March-April | April-June | June-August | October-November | March-June | |
| 2008 | 2008 | 2008 | 2008 | 2009 | |
| Survey 1 | Climate Schools Intervention | Survey 2 | Survey 3 | Survey 4 | |
| Survey 1 | Survey 2 | Survey 3 | Survey 4 |
Figure 1Consort flow diagram of recruitment and participation of schools.
Differences between students who were retained beyond baseline (repeat) and those that were lost to follow-up (single) on baseline scores
| Cannabis Knowledge | 8.58 | 8.78 | 1 | 1727 | 1.46 | p = 0.23 |
| Psychostimulant Knowledge | 8.26 | 8.51 | 1 | 1721 | 2.16 | p = 0.14 |
| Cannabis Attitudes | 9.64 | 8.24 | 1 | 1730 | 47.24 | p < 0.0001 |
| Psychostimulant Attitudes | 10.20 | 8.91 | 1 | 1730 | 41.57 | p < 0.0001 |
| Cannabis frequency of use (three months) | 0.47 | 0.12 | 1 | 1720 | 48.25 | p < 0.001 |
| Meth/amphetamine frequency of use (12 months) | 0.22 | 0.07 | 1 | 1727 | 17.61 | p < 0.001 |
| Ecstasy frequency of use (last 12 months) | 0.29 | 0.09 | 1 | 1727 | 29.8 | p < 0.001 |
| Cannabis intention 12 months | 1.10 | 0.60 | 1 | 1729 | 44.61 | p < 0.001 |
| Meth/amphetamine intention 12 months | 0.62 | 0.30 | 1 | 1727 | 38.20 | p < 0.001 |
| Ecstasy intention 12 months | 0.71 | 0.38 | 1 | 1727 | 29.66 | p < 0.001 |
| | | |||||
| Lifetime cannabis use | 0.22 | 0.10 | 1 | | 33.58 | p < 0.0001 |
| Lifetime Methamphetamine use | 0.10 | 0.03 | 1 | | 27.37 | p < 0.0001 |
| Lifetime ecstasy use | 0.12 | 0.05 | 1 | 32.2 | p < 0.0001 |
Mean knowledge and attitude scores (95% confidence intervals and sample size) for the intervention and control groups over time
| 8.81 | 9.25 | 9.14 | 9.51 | ||
| (8.63-8.98) | (9.04-9.46) | (8.87-9.41) | (9.24-9.78) | ||
| (n = 826) | (n = 576) | (n = 448) | (n = 403) | ||
| 8.69 | 10.76 | 10.42 | 10.39 | ||
| (8.52-8.86) | (10.58-10.94) | (10.22-10.62) | (10.17-10.61) | ||
| (n = 902) | (n = 627) | (n = 612) | (n = 570) | ||
| 8.49 | 9.08 | 8.89 | 9.34 | ||
| (8.31-8.67) | (8.86-9.30) | (8.60-9.18) | (9.05-9.63) | ||
| (n = 823) | (n = 577) | (n = 449) | (n = 403) | ||
| 8.45 | 10.46 | 10.25 | 10.28 | ||
| (8.27-8.63) | (10.26-10.66) | (10.03-10.47) | (10.04-10.52) | ||
| (n = 899) | (n = 627) | (n = 613) | (n = 569) | ||
| 8.86 | 8.71 | 8.61 | 8.85 | ||
| (8.62-9.10) | (8.46-8.96) | (8.32-8.90) | (8.54-9.16) | ||
| (n = 826) | (n = 578) | (n = 445) | (n = 403) | ||
| 8.13 | 8.04 | 8.30 | 7.95 | ||
| (7.93-8.33) | (7.80-8.28) | (8.05-8.55) | (7.70-8.20) | ||
| (n = 905) | (n = 626) | (n = 612) | (n = 568) | ||
| 9.36 | 9.55 | 9.34 | 9.68 | ||
| (9.14-9.58) | (9.30-9.80) | (9.05-9.63) | (9.37-9.99) | ||
| (n = 824) | (n = 577) | (n = 445) | (n = 403) | ||
| 8.93 | 8.88 | 8.96 | 8.74 | ||
| (8.71-9.15) | (8.63-9.13) | (8.71-9.21) | (8.49-8.99) | ||
| (n = 904) | (n = 626) | (n = 614) | (n = 568) |
aKnowledge scores can range from 0–15; with a higher score reflecting greater knowledge.
bAttitude scores range from 4–20; with a higher score reflecting a more positive attitude towards the use of drugs.
The proportion of students who reported having ever used cannabis, meth/amphetamine or ecstasy in their lifetime for the intervention and control groups over time (95% confidence intervals and sample size)
| 0.15 | 0.16 | 0.16 | 0.20 | ||
| (0.13-0.17) | (0.13-0.19) | (0.13-0.19) | (0.16-0.24) | ||
| (n = 828) | (n = 580) | (n = 450) | (n = 403) | ||
| 0.09 | 0.11 | 0.13 | 0.12 | ||
| (0.07-0.11) | (0.09-0.13) | (0.10-0.16) | (0.09-0.15) | ||
| (n = 903) | (n = 627) | (n = 614) | (n = 570) | ||
| 0.05 | 0.06 | 0.07 | 0.05 | ||
| (0.04-0.06) | (0.04-0.08) | (0.05-0.09) | (0.03-0.07) | ||
| (n = 827) | (n = 577) | (n =449) | (n = 403) | ||
| 0.04 | 0.03 | 0.05 | 0.04 | ||
| (0.03-0.05) | (0.02-0.04) | (0.03-0.07) | (0.02-0.06) | ||
| (n = 906) | (n = 627 | (n = 613) | (n = 570) | ||
| 0.07 | 0.09 | 0.09 | 0.07 | ||
| (0.05-0.09) | (0.07-0.11) | (0.07-0.12) | (0.05-0.09) | ||
| (n = 827) | (n = 580) | (n = 449) | (n = 403) | ||
| 0.05 | 0.05 | 0.06 | 0.06 | ||
| (0.04-0.07) | (0.03-0.06) | (0.04-0.08) | (0.04-0.08) | ||
| (n = 904) | (n = 627) | (n = 614) | (n = 569) |
Mean frequency of cannabis, meth/amphetamine and ecstasy use (95% confidence interval and sample size), for the intervention and control groups, over time
| 0.24 | 0.25 | 0.27 | 0.29 | ||
| (0.18-0.30) | (0.17-0.33) | (0.19-0.35) | (0.19-0.39) | ||
| (n = 823) | (n = 579) | (n = 447) | (n = 403) | ||
| 0.12 | 0.15 | 0.22 | 0.16 | ||
| (0.08-0.16) | (0.09-0.21) | (0.14-0.30) | (0.10-0.22) | ||
| (n = 898) | (n = 626) | (n = 614) | (n = 568) | ||
| 0.12 | 0.13 | 0.09 | 0.10 | ||
| (0.04-0.12) | (0.02-0.10) | (0.07-0.15) | (0.07-0.15) | ||
| (n = 824) | (n = 578) | (n = 449) | (n = 403) | ||
| 0.08 | 0.06 | 0.11 | 0.09 | ||
| (0.04-0.12) | (0.02-0.10) | (0.07-0.15) | (0.05-0.13) | ||
| (n = 904) | (n = 628) | (n = 614) | (n = 569) | ||
| 0.15 | 0.18 | 0.16 | 0.12 | ||
| (0.11-0.19) | (0.12-0.24) | (0.10-0.22) | (0.10-0.22) | ||
| (n = 824) | (n = 578) | (n = 447) | (n = 403) | ||
| 0.10 | 0.10 | 0.12 | 0.11 | ||
| (0.06-0.14) | (0.06-0.14) | (0.08-0.16) | (0.07-0.15) | ||
| (n = 904) | (n = 628) | (n = 614) | (n = 569) |
aFrequency was coded as: 0 = Have not used in the last 3 months, 1 = About once a month, 2 = Less than once a week, 3 = About once a week, 4 = More than once a week (but less than daily), 5 = Once a day, 6 = More than once per day.
bFrequency was coded as: 0 = Have not used in the last 12 months, 1 = once or twice a year, 2 = Every few months, 3 = About once a month, 4 = Once a week or more, 5 = every day.
Mean (95% confidence interval and sample size) likelihood ratings for using cannabis, methamphetamine or ecstasy in the next 12 months for the intervention and control groups on each survey occasion
| 0.82 | 0.92 | 0.93 | 0.95 | ||
| (0.74-0.90) | (0.80-1.04) | (0.79-1.07) | (0.81-1.09) | ||
| (n = 827) | (n = 579) | (n = 448) | (n = 403) | ||
| 0.56 | 0.62 | 0.72 | 0.61 | ||
| (0.48-0.64) | (0.54-0.70) | (0.62-0.82) | (0.51-0.71) | ||
| (n = 903) | N = 627 | (n = 614) | (n = 570) | ||
| 0.41 | 0.52 | 0.45 | 0.49 | ||
| (0.35-0.47) | (0.44-0.60) | (0.35-0.55) | (0.39-0.59) | ||
| (n = 827) | (n = 577) | (n = 447) | (n = 403) | ||
| 0.29 | 0.34 | 0.36 | 0.36 | ||
| (0.23-0.35) | (0.28-0.40) | (0.28-0.44) | (0.28-0.44) | ||
| (n = 902) | (n = 625) | (n = 614) | (n = 569) | ||
| 0.50 | 0.63 | 0.63 | 0.62 | ||
| (0.44-0.56) | (0.53-0.73) | (0.53-0.73) | (0.50-0.74) | ||
| (n = 823) | (n = 577) | (n = 445) | (n = 402) | ||
| 0.39 | 0.40 | 0.49 | 0.46 | ||
| (0.33-0.45) | (0.32-0.48) | (0.40-0.56) | (0.38-0.54) | ||
| (n = 905) | (n = 625) | (n = 614) | (n = 569) |